Analysts Anticipate Cerner Co. (NASDAQ:CERN) Will Post Earnings of $0.78 Per Share
Equities research analysts expect that Cerner Co. (NASDAQ:CERN) will post earnings per share of $0.78 for the current fiscal quarter, according to Zacks. Ten analysts have provided estimates for Cerner’s earnings, with the highest EPS estimate coming in at $0.79 and the lowest estimate coming in at $0.77. Cerner posted earnings of $0.75 per share in the same quarter last year, which would indicate a positive year-over-year growth rate of 4%. The business is expected to issue its next quarterly earnings report on Tuesday, February 2nd.
According to Zacks, analysts expect that Cerner will report full-year earnings of $2.84 per share for the current financial year, with EPS estimates ranging from $2.80 to $2.86. For the next financial year, analysts expect that the company will report earnings of $3.20 per share, with EPS estimates ranging from $3.05 to $3.40. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that follow Cerner.
Cerner (NASDAQ:CERN) last posted its quarterly earnings results on Wednesday, October 28th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.62 by $0.10. Cerner had a return on equity of 18.14% and a net margin of 14.28%.
NASDAQ:CERN opened at $73.25 on Tuesday. The firm has a market capitalization of $22.46 billion, a price-to-earnings ratio of 28.61, a PEG ratio of 2.80 and a beta of 0.76. Cerner has a 1-year low of $53.08 and a 1-year high of $80.90. The company has a current ratio of 2.29, a quick ratio of 2.28 and a debt-to-equity ratio of 0.30. The business’s fifty day moving average price is $72.89 and its 200 day moving average price is $70.97.
In related news, Director George Andrew Riedel sold 1,750 shares of the stock in a transaction that occurred on Monday, November 16th. The stock was sold at an average price of $75.69, for a total transaction of $132,457.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP John Peterzalek sold 46,729 shares of the stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $76.19, for a total value of $3,560,282.51. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 66,486 shares of company stock valued at $5,047,431. 0.33% of the stock is owned by corporate insiders.
A number of institutional investors have recently bought and sold shares of CERN. RTW Investments LP acquired a new position in Cerner in the 2nd quarter valued at approximately $81,054,000. BlackRock Inc. raised its holdings in Cerner by 4.0% in the 3rd quarter. BlackRock Inc. now owns 24,859,804 shares of the company’s stock valued at $1,797,114,000 after acquiring an additional 959,533 shares in the last quarter. Jupiter Asset Management Ltd. acquired a new position in Cerner in the 3rd quarter valued at approximately $52,938,000. Nordea Investment Management AB raised its holdings in Cerner by 107.4% in the 2nd quarter. Nordea Investment Management AB now owns 1,349,906 shares of the company’s stock valued at $91,524,000 after acquiring an additional 698,933 shares in the last quarter. Finally, Morgan Stanley raised its holdings in Cerner by 31.2% in the 1st quarter. Morgan Stanley now owns 2,868,059 shares of the company’s stock valued at $180,660,000 after acquiring an additional 682,655 shares in the last quarter. 72.19% of the stock is owned by hedge funds and other institutional investors.
Cerner Company Profile
Cerner Corporation, together with its subsidiaries, provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
See Also: Why are gap-down stocks important?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.